The cut-offs of high PD-L1 being 50% is also arbitrary and the levels can vary within different tumor regions (spatial heterogeneity) and change over time with dynamic changes due to response to therapy, inflammation, or natural history of cancer (temporal heterogeneity). The gene discussed is CD274; the disease is neoplasm.